Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma (Q42802688)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 June 2005
edit
Language Label Description Also known as
English
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma
scientific article published on 18 June 2005

    Statements

    Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma (English)
    0 references
    A N Alexander
    M K Huelsmeyer
    Ann Mitzey
    R R Dubielzig
    I D Kurzman
    E G Macewen
    18 June 2005
    433-442
    0 references
    0 references
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit